Life Science & Technology Weekly 157 – Ascentage Pharma Officially Announces its Hong Kong IPO

Life Science, Technology

MedMen Gains Exclusive Rights to Woodstock Name for Cannabis Products

Cannabis, Life Science

Evotec and Novo Nordisk Ink Deal to Develop Drugs for Obesity and Diabetes

Life Science

Sierra Oncology Acquires Gilead’s Momelotinib in $198 Million Deal

Life Science

Zai Lab Plans Hong Kong IPO to Raise up to $300 Million

Life Science

Canaccord’s Gordon Group Provides Update on Cannabis Industry in Ontario, Canada

Cannabis, Life Science

Marijuana stocks up after Ontario announces cannabis supply agreements

Cannabis, Life Science

Walmart and Anthem sign deal to expand access to over-the-counter medicines for seniors

Life Science

Roche Snags Chinese Approval for Lung Cancer Drug Alecensa

Life Science

Ascentage Pharma Officially Announces its Hong Kong IPO

Life Science

Ontario Cannabis Store announces supply agreements with 26 licensed producers

Cannabis, Life Science

Alphabet-backed One Medical is in talks to raise more than $200 million

Life Science

Harbour BioMed Inks Partnership Deal with Sichuan Kelun-Biotech Worth $350 Million-Plus

Life Science

China Biologic Management Makes $3.9 Billion Take-Private Offer

Life Science

Ottawa to review Constellation Brands’ blockbuster investment in Canopy Growth

Cannabis, Life Science